Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592462 · ClinicalTrials.gov registry record
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT00592462: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00592462 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592462 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The objective of this pilot study is to develop and evaluate a whole body MRI technique for detecting cancer metastases. The whole body MRI will include T1-weighted and T2-weighted phase-sensitive MR imaging as well as diffusion weighted imaging of the whole body in multiple patient table stations.
Interventions
- PROCEDURE Whole Body MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-12 |
| Est. Completion | 2015-12 |
What the finished NCT00592462 record still lists
NCT00592462 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Whole Body MRI is the first listed.
NCT00592462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00592462 about?
NCT00592462 is a clinical study titled "Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases". The objective of this pilot study is to develop and evaluate a whole body MRI technique for detecting cancer metastases. The whole body MRI will include T1-weighted and T2-weighted phase-sensitive MR imaging as well as diffusion weighted imaging of the whole body in multiple patient table stations.
What is the current status of trial NCT00592462?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2007-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00592462?
The interventions under investigation include: Whole Body MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00592462?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia